Related references
Note: Only part of the references are listed.Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGF beta 1 action and upregulating MMP14
Eszter Regos et al.
MATRIX BIOLOGY (2018)
Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx
Boyan Grigorov et al.
CELLULAR MICROBIOLOGY (2017)
Syndecans - key regulators of cell signaling and biological functions
Nikolaos A. Afratis et al.
FEBS JOURNAL (2017)
Syndecan-1 Limits the Progression of Liver Injury and Promotes Liver Repair in Acetaminophen-Induced Liver Injury in Mice
Eon Jeong Nam et al.
HEPATOLOGY (2017)
Proteoglycans, ion channels and cell-matrix adhesion
Ioli Mitsou et al.
BIOCHEMICAL JOURNAL (2017)
From Child-Pugh to Model for End-Stage Liver Disease Deciding Who Needs a Liver Transplant
Sheela S. Reddy et al.
MEDICAL CLINICS OF NORTH AMERICA (2016)
Proteoglycans in liver cancer
Kornelia Baghy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients
Jannemarie de Ridder et al.
ONCOTARGET (2016)
Syndecan-1 and Its Expanding List of Contacts
Mary Ann Stepp et al.
ADVANCES IN WOUND CARE (2015)
Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1Rv3 integrin complex in tumorigenesis and angiogenesis
Alan C. Rapraeger
FEBS JOURNAL (2013)
Syndecan-1 Serves as the Major Receptor for Attachment of Hepatitis C Virus to the Surfaces of Hepatocytes
Qing Shi et al.
JOURNAL OF VIROLOGY (2013)
Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance
Yiping Deng et al.
HEPATOLOGY (2012)
Hepatic expression and serum levels of syndecan 1 (CD 138) in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Syndecans as cell surface receptors: Unique structure equates with functional diversity
Youngsil Choi et al.
MATRIX BIOLOGY (2011)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C
Isabel Zvibel et al.
LIVER INTERNATIONAL (2009)
An Immunohistochemical Study of Colon Adenomas and Carcinomas: E-cadherin, Syndecan-1, Ets-1
Zsuzsanna Pap et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Model for end-stage liver disease (MELD) exception guidelines
Russell Wiesner et al.
LIVER TRANSPLANTATION (2006)
Syndecan-1 in B lymphoid malignancies
RD Sanderson et al.
ANNALS OF HEMATOLOGY (2002)
Share Paper
